http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2348431-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c9cd9998822b37f1c44f5a63eaa1da5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate | 2007-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a396b6c77d4fd891494436cea23d6c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e618ed3398e321ce3fafd3cb5a49e83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_191a92226e2cdfaba54aa3d92badd17b |
| publicationDate | 2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2348431-C1 |
| titleOfInvention | Method of treatment of steroid-dependent bronchial asthma |
| abstract | FIELD: medicine; pulmonology. n SUBSTANCE: baseline therapy is combined with introduction of Ronkoleukine inhaled in dosage 250 thousand ME with using nebuliser, and injected simultaneously. Introduction takes two stages, herewith at the first stage Ronkoleukine is injected intravenously drop-by-drop in dosage 250 thousand ME within course 3 procedures every 72 hours, while at the second stage Ronkoleukine is injected every 2 weeks hypodermically in external surface of a shoulder in dosage 250 thousand ME within course 4-6 procedures. n EFFECT: normalised immune disorders and relieved endobronchial inflammations. n 2 tbl, 3 ex |
| priorityDate | 2007-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.